Key result
The addition of amlodipine to hydrochlorothiazide lowered supine and upright arterial pressures compared to hydrochlorothiazide plus placebo.
Why the study?
Does amlodipine added to hydrochlorothiazide reduce arterial pressure in patients with inadequately controlled hypertension?
RCT (n=40)
Blinded
Does amlodipine added to hydrochlorothiazide reduce arterial pressure in patients with inadequately controlled hypertension?
The addition of amlodipine to hydrochlorothiazide safely enhances antihypertensive efficacy and may have favorable effects on lipid profiles.
Answers are grounded in this paper and cite their sources.
Supports adding amlodipine to hydrochlorothiazide for uncontrolled hypertension; extends RCT evidence for combination regimens.
The antihypertensive and metabolic effects of amlodipine, a new calcium-channel blocker, in combination with hydrochlorothiazide (HCTZ) were compared with those of HCTZ in combination with placebo. After four weeks open treatment with HCTZ 50 mg/d, 20 patients were blindly allocated to receive placebo and 20 to receive amlodipine, if their diastolic arterial pressure supine and upright was 95 to 115 mm Hg. The patients were seen in the clinic every two weeks for 12 more weeks, where their arterial pressure (AP) and heart rate (HR) were measured supine and upright. Hydrochlorothiazide was kept at 50 mg/d, but amlodipine was increased from 2.5 to 5.0 to 10.0 mg/d as needed. At end of weeks 4 and 16 the AP and HR were measured hourly for 12 hours and 24 hours later. Serial clinical and laboratory evaluations including lipid profiles were done on all patients. Amlodipine treated patients had lower arterial pressures in both the supine and upright positions (P less than .001), higher HDL levels (P less than .05) and lower CHOL:HDL and LDL:HDL ratios (P less than .01), than placebo-treated patients. Also, amlodipine-treated patients had lower SGOT and SGPT levels (P less than .01) than placebo-treated patients. No changes in HR or weight were noted between the two groups of patients. Clinical side effects were few and mild and not different between the two groups. We conclude: (1) the addition of amlodipine to HCTZ enhanced its antihypertensive action; (2) amlodipine was safe and well tolerated; and (3) amlodipine, perhaps, has a favorable effect on lipids.
No takes yet. Share an insight, caveat, or question.
Chrysant et al. (1989) conducted an RCT in Hypertension (n=40). Amlodipine vs. Placebo was evaluated on Arterial pressure (p=<0.001). The addition of amlodipine to hydrochlorothiazide lowered supine and upright arterial pressures compared to hydrochlorothiazide plus placebo.
Synapse has enriched 10 related papers. Consider them for comparative context: